NCT05312710View on ClinicalTrials.gov

Safety and Efficacy of APG-157 in Head and Neck Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Head and Neck CancerSquamous Cell Carcinoma of Oral CavitySquamous Cell Carcinoma of the Oropharynx
Interventions
DRUG

APG-157

Treatment

Trial Locations (2)

33136

RECRUITING

University of Miami Sylvester Comprehensive Cancer Center, Miami

90073

RECRUITING

VAGLAHS, West Los Angeles, Los Angeles

Sponsors
All Listed Sponsors
lead

Aveta Biomics, Inc.

INDUSTRY

NCT05312710 - Safety and Efficacy of APG-157 in Head and Neck Cancer | Biotech Hunter | Biotech Hunter